Skip to main content
Fig. 1 | Experimental Hematology & Oncology

Fig. 1

From: Identification of adenoid subtype characterized with immune-escaped phenotype in lung squamous carcinoma based on transcriptomics

Fig. 1

Identification of LASC as a novel subtype in LUSC. A Unsupervised clustering of LUAD, LUSC, and LASC samples. B, C Expression levels of KRT7, KRT18, NAPSA, KRT5, TP63, and DSG3 in LUAD (n = 512), LUSC (n = 430), and LASC (n = 66) samples. Significance was calculated with One-way ANOVA with Tukey’s multiple comparisons test. ns no statistical difference, **P < 0.01, ***P < 0.001. D Mutant profiles of EGFR, KEAP1, KRAS, STK11, TP53, CDKN2A, PIK3CA, ROS1, and NF1 in LUAD, LUSC, and LASC samples. E Prognostic analysis of patients in LUAD, LUSC, and LASC subtypes. Significance was calculated with log-rank test

Back to article page